Dr. Mark Silverberg, MD, PhD
Samuel Lunenfeld Research Institute of Mount Sinai Hospital
I feel that the significant transformation in how and what we eat over the last several decades has a critical role in the rapid rise of many modern diseases such as inflammatory bowel disease.
Mark Silverberg, MD, PhD completed his internal medicine and gastroenterology training at the University of Toronto in 1997. He then completed a PhD studying the genetics of inflammatory bowel disease (IBD) in 2002 at the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital (MSH).
He is currently a Gastroenterologist helping patients with inflammatory bowel disease. He is a Professor in the Department of Medicine at the University of Toronto and the Gale and Graham Wright Research Chair in Digestive Diseases at the Zane Cohen Centre at MSH. His research program is funded by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH), CIHR and Crohn’s and Colitis Canada (CCC). His laboratory is focused on elucidating the genetic and microbial contributors to the pathogenesis of IBD and to identify biomarkers relevant to its clinical course.
He has made significant contributions to the discovery of genes related to Crohn’s disease, ulcerative colitis and pediatric IBD as well as being a major contributor to the field of phenomics and classification of IBD (The Montreal Classification). Dr. Silverberg’s research is currently focusing on the role the diet plays in managing IBD and how environmental factors alter the gut microbiome.
Dr. Silverberg has taken leadership positions on several international collaborative efforts with the goal of expediting scientific progress in the field of IBD. These include the International IBD Genetics Consortium and the NIDDK/NIH IBD Genetics Consortium. Dr. Silverberg is also the Director of the Advanced IBD Fellowship Program at MSH and co-director of the Canadian GI Fellows Program in IBD. He is currently a member of the International Organization for the study of Inflammatory Bowel Disease (IOIBD) the Chair of the Scientific and Medical Advisory Council of Crohn’s and Colitis Canada and Chair of the IMIBD Section of the American Gastroenterological Association Council.
Looking Ahead to the Future of Gastroenterology
What can we expect in the future for gastroenterology? How will our understanding of the microbiome influence this field of medicine? The microbes that make up our microbiome can have such far reaching effects throughout the entire body.